CEA, AFP, CA125, CA153 and CA199 in Malignant Pleural Effusions Predict the Cause

Thyroid Transcription Factor 1 and Napsin A Double Staining in Lung Adenocarcinoma in Pleural Fluid

(2012) Lian Liu et al.   ACTA CYTOLOGICA

Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

(2010) N. Pavlidis et al.   ANNALS OF ONCOLOGY

Expression and Clinical Role of Antiapoptotic Proteins of the Bag, Heat Shock, and Bcl-2 Families in Effusions, Primary Tumors, and Solid Metastases in Ovarian Carcinoma

(2009) Mari Bunkholt Elstrand et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Immunzytochemische Abklärung des initialen CUP-Syndroms an Feinnadelpunktaten

(2009) A. Böcking et al.   PATHOLOGE

Pleurésies malignes révélatrices d’un cancer : comparaison des étiologies avec les pleurésies métastatiques d’un cancer connu

(2009) L. Cellerin et al.   REVUE DES MALADIES RESPIRATOIRES

Diagnostic utility of LunXmRNA in peripheral blood and pleural fluid in patients with primary non-small cell lung cancer

(2008) Min Cheng et al.   BMC CANCER

Utility of cytology microarray constructed from effusion cell blocks for immunomarker validation

(2008) Robert T. Pu et al.   CANCER

Transcription expression and clinical significance of TTF-1 mRNA in pleural effusion of patients with lung cancer

(2008) Bing Jiang et al.   DIAGNOSTIC CYTOPATHOLOGY

Combined FDG-PET/CT for the detection of unknown primary tumors: systematic review and meta-analysis

(2008) Thomas C. Kwee et al.   EUROPEAN RADIOLOGY

Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology

(2008) Thomas C. Kwee et al.   EUROPEAN RADIOLOGY

Diagnostic accuracy of tumour markers for malignant pleural effusion: a meta-analysis

(2007) Q-L Liang et al.   THORAX